<code id='A7AC4010DA'></code><style id='A7AC4010DA'></style>
    • <acronym id='A7AC4010DA'></acronym>
      <center id='A7AC4010DA'><center id='A7AC4010DA'><tfoot id='A7AC4010DA'></tfoot></center><abbr id='A7AC4010DA'><dir id='A7AC4010DA'><tfoot id='A7AC4010DA'></tfoot><noframes id='A7AC4010DA'>

    • <optgroup id='A7AC4010DA'><strike id='A7AC4010DA'><sup id='A7AC4010DA'></sup></strike><code id='A7AC4010DA'></code></optgroup>
        1. <b id='A7AC4010DA'><label id='A7AC4010DA'><select id='A7AC4010DA'><dt id='A7AC4010DA'><span id='A7AC4010DA'></span></dt></select></label></b><u id='A7AC4010DA'></u>
          <i id='A7AC4010DA'><strike id='A7AC4010DA'><tt id='A7AC4010DA'><pre id='A7AC4010DA'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:3
          A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home
          A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

          Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

          STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways. 

          advertisement

          The ‘razor blade’ business model 

          Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes —  almost 70% of its $184 million revenue in 2023 came from these supplies. 

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Study: Hearing aids may slow cognitive decline in those at risk
          Study: Hearing aids may slow cognitive decline in those at risk

          FREDTANNEAU/AFPviaGettyImagesDoctorshavelongsuspectedthathearinglossinolderadultshastensdementia,the

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Flagship, Pfizer team up in deal worth up to $7 billion

          PaulBiondiFlagshipPharmagiantPfizeristurningtoventurefirmFlagshipfornewdrugdevelopment,signingadealw